References:

• Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues.

  Hanna BS, Roessner PM, Yazdanparast H, Colomer D, Campo E, Kugler S, Yosifov D, Stilgenbauer S, Schmidt M, Gabriel R, Lichter P, Seiffert M.
  Leukemia. 2019 Mar;33(3):625-637. doi: 10.1038/s41375-018-0250-6. Epub 2018 Sep 28.

• Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

  Rossi D, Rasi S, Spina V, Bruscaggin A, Monti S, Ciardullo C, Deambrogi C, Khiabanian H, Serra R, Bertoni F, Forconi F, Laurenti L, Marasca R, Dal-Bo M, Rossi FM, Bulian P, Nomdedeu J, Del Poeta G, Gattei V, Pasqualucci L, Rabadan R, Foà R, Dalla-Favera R, Gaidano G.
  Blood. 2013 Feb 21;121(8):1403-12. doi: 10.1182/blood-2012-09-458265. Epub 2012 Dec 13.

• Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.

  Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J, Grunn A, Fangazio M, Capello D, Monti S, Cresta S, Gargiulo E, Forconi F, Guarini A, Arcaini L, Paulli M, Laurenti L, Larocca LM, Marasca R, Gattei V, Oscier D, Bertoni F, Mullighan CG, Foá R, Pasqualucci L, Rabadan R, Dalla-Favera R, Gaidano G.
  J Exp Med. 2011 Jul 4;208(7):1389-401. doi: 10.1084/jem.20110921. Epub 2011 Jun 13.

• Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.

  Puente XS, Pinyol M, Quesada V, Conde L, Ordóñez GR, Villamor N, Escaramis G, Jares P, Beà S, González-Díaz M, Bassaganyas L, Baumann T, Juan M, López-Guerra M, Colomer D, Tubío JM, López C, Navarro A, Tornador C, Aymerich M, Rozman M, Hernández JM, Puente DA, Freije JM, Velasco G, Gutiérrez-Fernández A, Costa D, Carrió A, Guijarro S, Enjuanes A, Hernández L, Yagüe J, Nicolás P, Romeo-Casabona CM, Himmelbauer H, Castillo E, Dohm JC, de Sanjosé S, Piris MA, de Alava E, San Miguel J, Royo R, Gelpí JL, Torrents D, Orozco M, Pisano DG, Valencia A, Guigó R, Bayés M, Heath S, Gut M, Klatt P, Marshall J, Raine K, Stebbings LA, Futreal PA, Stratton MR, Campbell PJ, Gut I, López-Guillermo A, Estivill X, Montserrat E, López-Otín C, Campo E.
  Nature. 2011 Jun 5;475(7354):101-5. doi: 10.1038/nature10113.

• NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.

  Rosati E, Baldoni S, De Falco F, Del Papa B, Dorillo E, Rompietti C, Albi E, Falzetti F, Di Ianni M, Sportoletti P.
  Front Oncol. 2018 Jun 27;8:229. doi: 10.3389/fonc.2018.00229. eCollection 2018. Review. PMID: 29998084

• Molecular pathogenesis of chronic lymphocytic leukemia.

  Gaidano G, Foà R, Dalla-Favera R.
  J Clin Invest. 2012 Oct;122(10):3432-8. doi: 10.1172/JCI64101. Epub 2012 Oct 1. Review.

• Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?

  Rosenquist R, Cortese D, Bhoi S, Mansouri L, Gunnarsson R.
  Leuk Lymphoma. 2013 Nov;54(11):2351-64. doi: 10.3109/10428194.2013.783913. Epub 2013 Apr 30. Review.